Adherence measurement considerations for oral antiretroviral medications
Corwin Coppinger, Peter L Anderson · 2024
Read Adherence measurement considerations for oral antiretroviral medications by Corwin Coppinger, Peter L Anderson (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11589385.txt.
Description
Corwin Coppinger and Peter Anderson argue that how trials measure pill-taking can quietly mislead HIV prevention science. Their 2024 viewpoint covers oral drugs for treatment and for pre-exposure prophylaxis, where skipping doses is the strongest known predictor of failure. Early trials leaned on self-reports and pill counts, which claimed use above 90 percent.
Blood tests told another story: drug levels were often low or absent, above all in people who went on to contract HIV. Some participants, the authors say, never meant to take the pills, and staff could not tell. The only way to spot that intent is to ask, yet asking invites polished answers. The pair call for adherence measures built with this hidden intent in mind. Open, non-judging talk with participants is part of the fix.
Catalog record
| CREATOR | Corwin Coppinger, Peter L Anderson |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 10 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |